PATENT CLAIM ANALYSIS

Application Number: 16109643
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "309000"]

Abstract:
Provided herein are compounds of Formula I, or a pharmaceutically acceptable salt thereof: which are useful as PARP inhibitors, as well as pharmaceutical compositions comprising them and methods for their use in treating disorders.

Claim (Index 15):
A method of sensitizing a cell to a DNA-damaging agent, the method comprising administering to a human in need thereof a pharmaceutically effective amount of a compound of  claim 1 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 96.0
- Lexical Diversity: 1.11765
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11535127', '10271715', '11567352', '14647088', '14991815']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7387800326079509
- 35 USC 102 Novelty (BERT): 0.5260015249486927
- Combined Prediction Score: 0.7175021818420251
- Mean Citation Score: 283.654396
- Max Citation Score: 287.6168
- Similarity Product: 167.94880251893997

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test